Roles of Oxidative Stress in Policystic Ovary Syndrome

1. Hoffman B.L., Shorge O.J, Bradshaw D.K., Halvorson M.L., Schaffer I.J., Corton M.M. (2016.) Williams Gyneclogy (3th ed), New York, USA: Mc Graw Hill Education.Search in Google Scholar

2. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction.2004; 19(1): 41–47.10.1093/humrep/deh098Search in Google Scholar

3. Al-Gugory KH, Fowler PA, Garrel C. The role of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcome. Int J Biochem. 2010; 42: 1634-50.10.1016/j.biocel.2010.06.001Search in Google Scholar

4. Burton G.J., Jauniaux E. Oxidative stress. Best Pract. Res. Clin. Obstet. Gynaecol. 2011; 25(3): 287-99.10.1016/j.bpobgyn.2010.10.016Search in Google Scholar

5. Agarwal A, Saleh RA, Bedaiwy MA: Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003; 79: 829-843.10.1016/S0015-0282(02)04948-8Search in Google Scholar

6. Bellver J, Melo MA, Bosch E, Sewa V, Remotin J, Pellier A. Obesity and poor reproductive outcome; the potential role of the endometrium. Fertil Steril. 2007; 88(2): 446-51.10.1016/j.fertnstert.2006.11.16217418840Search in Google Scholar

7. Zhao Y, Zhang C, Huang Y, Yu Y, Li R, Li M, et al. Upregulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-kB signaling in the granulosa cells of PCOS patients. J Clin Endocrinol Metab. 2015; 100: 201–11.10.1210/jc.2014-241925303486Search in Google Scholar

8. Escobar-Morreale, H.F., Luque-Ramírez, M., González, F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011; 95:1048–58.10.1016/j.fertnstert.2010.11.036307956521168133Search in Google Scholar

9. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006; 91: 336–40.10.1210/jc.2005-169616249279Search in Google Scholar

10. Victor VM, Rocha M, Bañuls C, Sanchez-Serrano M, Sola E, Gomez M, et al. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2009; 94: 3505–12.10.1210/jc.2009-046619567514Search in Google Scholar

11. Victor VM, Rocha M, Bañuls C, Alvarez A, de Pablo C, Sanchez-Serrano M, et al. Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2011; 96: 3115–22.10.1210/jc.2011-065121778215Search in Google Scholar

12. Gonzalez F, Rote NS, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor alpha release in obese women with polycystic ovary syndrome. J Endocrinol. 2006; 188: 521–29.10.1677/joe.1.0657916522732Search in Google Scholar

13. Orio F Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanovà L, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90: 2–5.10.1210/jc.2004-062815483098Search in Google Scholar

14. Miyamoto K, Sato EF, Kasahare E, Jikumaru M, Hiramoto K, Tabate H, et al. Effect of oxidative stress during repeated ovulation on the structure and function of the ovary, oocyte and the mitochondria. Free Radical Biol Med. 2010; 49(4): 674-8110.1016/j.freeradbiomed.2010.05.02520621580Search in Google Scholar

15. Mohammadi M. Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review.Int J Prev Med. 2019; 10: 86.10.4103/ijpvm.IJPVM_576_17654778531198521Search in Google Scholar

16. Özer A, Bakacak M, Kıran H, Ercan Ö, Köstü B. Increased oxidative stress is associated with insulin resistance and infertility in policistic ovarian sindrome. Ginekologia Polska. 2016; 87(11): 733–38.10.5603/GP.2016.007927958630Search in Google Scholar

17. Panti A, Shehu C, Saidu Y, et al. Oxidative stress and outcome of antioxidant supplementation in patients with polycystic ovarian syndrome (PCOS). Int J Reprod Contracept Obstet Gynecol. 2018; 7: 1667–72.10.18203/2320-1770.ijrcog20181892Search in Google Scholar

18. Victor VM, Rovira-Llopis S, Bañuls C, DiazMorales N, Martinez de Marañon A, Rios-Navarro C, et al. Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase. PLoS One.2016; 11(3): e015-1960.10.1371/journal.pone.0151960480529727007571Search in Google Scholar

19. Gyftaki R, Gougoura S, Kalogeris N, Loi V, Koukoulis G, Vryonidou A. Oxidative stress markers in women with polycystic ovary syndrome without insulin resistance. Endocrine Abstracts. 2018; 56: 950.10.1530/endoabs.56.P950Search in Google Scholar

20. Uyanikoglu H, Icon O, Sabuncu T, Dursun H, Sezen h & Aksoy N, Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study. Journal Biomarkers. 2017; 22(7): 643-47.10.1080/1354750X.2016.1265004Search in Google Scholar

21. Deepika M.L.N, K Nalini S, Maruthi G,Ramchander V, Ranjith K, Latha P, Usha Rani V. and Jahan P. Analysis of Oxidative Stress Status Through MN Test and Serum MDA Levels in PCOS Women. Pakistan Journal of Biological Sciences. 2014; 17: 574-77.10.3923/pjbs.2014.574.57725911850Search in Google Scholar

22. Chen L, Ming Xu W, Zhang D, Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertility and Sterility. 2014; 102(4): 1167-74.10.1016/j.fertnstert.2014.06.02725064406Search in Google Scholar

23. Kim E-J, Jang M, Choi JH, Park KS and Cho I-H. An Improved Dehydroepiandrosterone-Induced Rat Model of Polycystic Ovary Syndrome (PCOS): Post-pubertal Improve PCOS’s Features. Front. Endocrinol. 2018; 9: 735.10.3389/fendo.2018.00735Search in Google Scholar

24. Wang Y. et al.: Eicosapentaenoic acid improves polycystic ovary syndrome. Med Sci Monit. 2018; 24: 2091-97.10.12659/MSM.909098590762429627845Search in Google Scholar

25. Sanaz Alivandi F, Khazali H. Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycinemax L. Merrill) in rats with estradiol valerateinduced polycystic ovary syndrome as an inflammatory state. Gynecological Endocrinology.2019;35(12):1078-83.10.1080/09513590.2019.162471531185755Search in Google Scholar

26. Çelik L.S, Kuyucu Y, Yenilmez E.D, Tuli A, Dağlıoğlu K& Özgü M. U. Effects of vitamin D on ovary in DHEAtreated PCOS rat model: A light and electron microscopic stud. Ultrastructural Pathology.2017;42(6): 55-64.10.1080/01913123.2017.1385668Search in Google Scholar